CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages by Kirchheiner J, Brøsen K, Dahl M L, Gram L F, Kasper S, Roots I, Sjöqvist F, Spina E, Brockmöller J in Acta psychiatrica Scandinavica (2001). PubMed


This review aimed to provide distinct dose recommendations for antidepressants based on the genotypes of cytochrome P450 enzymes CYP2D6 and CYP2C19. This approach may be a useful complementation to clinical monitoring and therapeutic drug monitoring.

[ hide abstract ]

Discussed In Paper